Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cabenuva
Pharma
GSK props up its Cabenuva in adolescents with long-term data
GSK's every-two-month injection kept adolescents with HIV virologically suppressed at 96 weeks, GSK's ViiV presented at a recent medical conference.
Zoey Becker
Feb 26, 2026 1:00pm
Pfizer unleashes its stake in GSK's ViiV Healthcare for $1.9B
Jan 20, 2026 10:15am
GSK allows generic versions of cabotegravir for HIV treatment
Jul 15, 2025 2:16pm
Vyvgart, Cabenuva, Lumakras top Trinity launch success analysis
Mar 12, 2025 2:13pm
GSK bolsters case for long-acting HIV PrEP drug Apretude
Oct 16, 2024 1:26pm
GSK to triple long-acting Apretude supply to boost global access
Oct 7, 2024 10:56am
